Boston Scientific Corp (BSX)
104.48
-0.02
(-0.02%)
USD |
NYSE |
May 23, 16:00
104.70
+0.22
(+0.21%)
After-Hours: 18:08
Boston Scientific Cash from Investing (Quarterly): -500.00M for March 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -470.00M |
| Integer Holdings Corp | -197.17M |
| Masimo Corp | 10.70M |
| ResMed Inc | -31.79M |
| Stryker Corp | -4.136B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 541.00M |
| Cash from Financing (Quarterly) | 233.00M |
| Free Cash Flow | 2.723B |
| Free Cash Flow Per Share (Quarterly) | 0.1855 |
| Free Cash Flow to Equity (Quarterly) | -286.00M |
| Free Cash Flow to Firm (Quarterly) | 345.45M |
| Free Cash Flow Yield | 1.75% |